Voyager Therapeutics, Inc. Quarterly Marketable Securities, Current in USD from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Voyager Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2017 to Q2 2024.
  • Voyager Therapeutics, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $295M, a 936% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $295M +$266M +936% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $256M +$251M +5037% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $162M +$142M +715% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $188M +$153M +440% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $28.5M -$41.3M -59.2% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $4.99M -$30M -85.7% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $19.9M +$4.78M +31.7% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $34.8M +$24.8M +247% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $69.7M +$44.6M +177% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $35M -$8.75M -20% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $15.1M -$61.6M -80.3% Dec 31, 2021 10-K 2023-03-07
Q3 2021 $10M -$42.5M -80.9% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $25.1M -$60.2M -70.5% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $43.7M -$42M -49% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $76.7M -$119M -60.8% Dec 31, 2020 10-K 2022-03-08
Q3 2020 $52.6M -$172M -76.6% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $85.3M -$162M -65.5% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $85.7M -$160M -65.1% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $195M +$86.5M +79.4% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $225M +$87.3M +63.5% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $248M +$111M +81.4% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $245M +$167M +215% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $109M -$28.6M -20.8% Dec 31, 2018 10-K 2020-03-03
Q3 2018 $137M Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $137M Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $77.8M Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $138M Dec 31, 2017 10-K 2019-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.